Ravi Jhaveri MD

After having served on the faculty at both Duke and UNC, Dr. Ravi R Jhaveri, MD, joined the faculty at Lurie/FSM in October 2018. He currently serves as Associate Division Head for Pediatric Infectious Diseases. Dr. Jhaveri is active in the leadership of several infectious disease societies at the national level. He currently serves as a member of the Pediatric Infectious Diseases Society Board of Directors. He is the Vice-Chair of the Infectious Diseases Society of America Leadership Institute working group and is the PIDS liaison to the IDSA Standards, Practice, and Guidelines Committee. He is a member of the AASLD-IDSA HCV Guidelines committee, where he serves as one of the subgroup chairs on HCV in Children and Pregnant Women.

Dr. Jhaveri has focused on all aspects of Hepatitis C virus infection. In the past, he ran a laboratory dedicated to studying the effect of HCV on lipid metabolism in liver cells and viral and host determinants of HCV vertical transmission. He has been very active in studies of HCV in infants and children: epidemiology, natural history, treatment, testing, and advocacy. Dr. Jhaveri's other interests include outcomes studies in pediatric infectious diseases, influenza, and the live-attenuated influenza vaccine, prevention, treatment, and vertical transmission of Hepatitis B, management of febrile infants, and physician decision-making. Dr. Jhaveri's clinical practice is in all aspects of pediatric infectious diseases. His specialty is in the management of children with Hepatitis B & C exposure and infection.